These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2154826)

  • 1. Evidence for four opioid kappa binding sites in guinea pig brain.
    Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
    Prog Clin Biol Res; 1990; 328():9-12. PubMed ID: 2154826
    [No Abstract]   [Full Text] [Related]  

  • 2. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
    Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
    Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
    Li JG; Ma SC; Lu SN; Wang CQ
    Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
    Frances B; Moisand C; Meunier JC
    Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-Pro10]Dynorphin-(1-11) is a highly potent and selective ligand for kappa opioid receptors.
    Gairin JE; Gouarderes C; Mazarguil H; Alvinerie P; Cros J
    Eur J Pharmacol; 1984 Nov; 106(2):457-8. PubMed ID: 6152222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis and analgesic activity of 3,4-dichloro-N-methyl-N-[trans-2-(1-delta 3-pyrrolinyl)-cyclohexyl]-benzenacetamide hydrochloride].
    Ma SC; Lu SN; Li KZ; Wang CQ
    Yao Xue Xue Bao; 1986 Nov; 21(11):861-3. PubMed ID: 3035865
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
    Morris BJ; Herz A
    Neuroscience; 1986 Nov; 19(3):839-46. PubMed ID: 3025770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.
    Utz J; Eckert R; Trautwein W
    J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ; Blanchard SG; Cuatrecasas P
    Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
    de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
    J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel series of potent and selective agonists at the opioid kappa-receptor.
    Costello GF; Main BG; Barlow JJ; Carroll JA; Shaw JS
    Eur J Pharmacol; 1988 Jul; 151(3):475-8. PubMed ID: 2850924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]U-69593 a highly selective ligand for the opioid kappa receptor.
    Lahti RA; Mickelson MM; McCall JM; Von Voigtlander PF
    Eur J Pharmacol; 1985 Feb; 109(2):281-4. PubMed ID: 2986999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure.
    Negus SS; Picker MJ; Dykstra LA
    NIDA Res Monogr; 1989; 95():518-9. PubMed ID: 2561845
    [No Abstract]   [Full Text] [Related]  

  • 19. The affinity ligand "UPHIT" acylates kappa opioid binding sites in vivo.
    Band L; de Costa BR; Bykov V; Pert A; Rice KC; Rothman RB
    Prog Clin Biol Res; 1990; 328():77-80. PubMed ID: 2154823
    [No Abstract]   [Full Text] [Related]  

  • 20. A new analysis of whole-body calorimetry data.
    Lynch TJ; Martinez RP; Furman MB; Geller EB; Adler MW
    NIDA Res Monogr; 1989; 95():289-90. PubMed ID: 2561834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.